Related Experiment Video
Updated: Jun 16, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Ischaemic stroke complicating primary percutaneous coronary intervention in patients with ST elevation myocardial
Mehmet Ergelen1, Sevket Gorgulu, Huseyin Uyarel
1Dept. of Cardiology, Siyami Ersek Thoracic and Cardiovascular Surgery Centre, Training and Research Hospital, Istanbul, Turkey. drmerg@hotmail.com
Insights
Ischaemic stroke occurs in 0.73% of ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI), increasing mortality. Low ejection fraction and contrast nephropathy predict stroke, while tirofiban may offer protection.
Area of Science:
- Cardiology
- Neurology
- Interventional Cardiology
Background:
- ST-elevation myocardial infarction (STEMI) is a critical condition requiring timely intervention.
- Primary percutaneous coronary intervention (PCI) is the standard treatment for STEMI.
- Ischaemic stroke is a serious complication that can occur during or after PCI.
Purpose of the Study:
- To determine the in-hospital incidence of ischaemic stroke in STEMI patients undergoing primary PCI.
- To identify predictors of ischaemic stroke in this patient population.
- To assess the impact of ischaemic stroke on in-hospital cardiovascular mortality.
Main Methods:
- Retrospective review of 2638 consecutive STEMI patients undergoing 2722 primary PCI procedures.
- Definition of ischaemic stroke: new focal neurological deficit lasting > or =24 hours, excluding haemorrhagic stroke.
- Analysis of clinical characteristics and in-hospital outcomes related to ischaemic stroke.
Main Results:
- Ischaemic stroke incidence was 0.73% (20/2722 procedures).
- Stroke patients were older, with higher prevalence of female gender, diabetes, and hypertension.
- Independent predictors for ischaemic stroke included left ventricular ejection fraction (LVEF) < 35% and contrast-induced nephropathy; tirofiban use showed a protective effect.
Conclusions:
- Ischaemic stroke incidence in STEMI patients undergoing PCI is significant and associated with increased in-hospital mortality.
- Low LVEF (<35%) and contrast-induced nephropathy are independent predictors of ischaemic stroke.
- Tirofiban use may have a protective role against ischaemic stroke in STEMI patients undergoing PCI.
Objective:
We sought to determine the in-hospital incidence and predictors of ischaemic stroke in patients with ST elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).
Methods:
We reviewed 2638 consecutive patients undergoing 2722 pimary PCI procedures for STEMI during in-hospital stay. Stroke was defined as any new focal neurological deficit lasting > or =24 h, occurring anytime during or after PCI until discharge. Patients with haemorrhagic stroke were excluded. Clinical characteristics and in-hospital outcome were analysed regarding ischaemic stroke in patients undergoing primary PCI.
Results:
Ischaemic stroke was observed in 20 of the 2722 procedures, an incidence of 0.73%. Patients with ischaemic stroke were older than patients without stroke (mean age 67 +/- 9.6 vs. 56.6 +/- 11.8, P < 0.001). Compared to patients without stroke, female gender, diabetes and hypertension were more prevalent in patients with stroke. Ischaemic stroke was found to be a powerful independent predictor of in-hospital cardiovascular mortality (odds ratio [OR] 6.32, 1.15-34.7; P < 0.001). Left ventricular ejection fraction (LVEF) < 35% (OR 3.13, P = 0.04), contrast-induced nephropathy (OR 2.91, P = 0.04) and tirofiban use (OR 0.23, P = 0.02) were the independent predictors for in-hospital ischaemic stroke.
Conclusions:
The present study shows that the incidence of ischaemic stroke in patients undergoing PCI for STEMI is higher and ischaemic stroke increases in-hospital mortality in these patients. Moreover, LVEF < 35% and contrast-induced nephropathy were independent predictors of ischaemic stroke, whereas tirofiban use demonstrated a protective effect to this potentially catastrophic complication.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
